Haematologica, Vol 92, Issue 11, 1581-1582 doi:10.3324/haematol.10260
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stanulla, M.
Right arrow Articles by Schrappe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanulla, M.
Right arrow Articles by Schrappe, M.

Acute Lymphoblastic Leukemia

The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group

Martin Stanulla*,, Christian Dynybil*, Dorothee B. Bartels°, Michael Dördelmann#, Lutz Löning@, Alexander Claviez^, Martin Schrappe^

* Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany;
° Department of Epidemiology, Social Medicine and Heatlh System Research, Hannover Medical School, Hannover, Germany;
# Department of Pediatric Pulmonology and Neonatology, Hannover Medical School, Hannover, Germany;
@ Department of Pediatrics; City Hospital; Oldenburg, Germany;
^ University Children’s Hospital, Kiel, Germany

Correspondence: Martin Stanulla, M.D., M.Sc., Department of Pediatric Hematology and Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Phone: international +49.511.532 6712. Fax: international +49.5115329029. E-mail: stanulla.martin{at}mh-hannover.de

In a matched-pair study, we analyzed the association of a phenotypically relevant NQO1 polymorphism (C609T) with risk of secondary malignant neoplasms (SMN) after treatment for childhood acute lymphoblastic leukemia. Patients carrying a variant low-activity NQO1 allele had a significantly increased risk of developing a SMN. The observed effect was restricted to solid tumors.

Key words: acute lymphoblastic leukemia, childhood, secondary malignant neoplasms, NQO1, polymorphism.




This article has been cited by other articles:


Home page
 BloodHome page
K. Schmiegelow, I. Al-Modhwahi, M. K. Andersen, M. Behrendtz, E. Forestier, H. Hasle, M. Heyman, J. Kristinsson, J. Nersting, R. Nygaard, et al.
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
Blood, June 11, 2009; 113(24): 6077 - 6084.
[Abstract] [Full Text] [PDF]